Hot Features
プレミアム
登録してリアルタイムのチャート、分析ツール、価格を入手してください。
| 名称 | 銘柄コード | 市場 | 種別 |
|---|---|---|---|
| XBiotech Inc | XBIT | NASDAQ | 普通株式 |
| 前日比 | 前日比 % | 現在値 | 時刻
|
|
|---|---|---|---|---|
| -0.14 | -1.72% | 8.02 | 05:06:26 |
| 始値 | 安値 | 高値 | 終値 | 前日終値 |
|---|---|---|---|---|
| 8.26 | 8.02 | 8.69 | 8.02 | 8.16 |
最新ニュース
| 日付 | 時間 | ソース | タイトル |
|---|---|---|---|
| 2024/2/08 | 02:36 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 2024/2/08 | 02:01 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 2024/1/06 | 00:48 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2024/1/04 | 23:00 | EDGAR2 | Form 8-K - Current report |
| 2024/1/04 | 23:00 | GLOBE | XBiotech to Begin Constructing New R&D Facility on its.. |
| 2023/11/14 | 23:00 | GLOBE | Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in.. |
| 2023/11/10 | 04:41 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 2023/9/26 | 22:00 | GLOBE | XBiotech Announces Enrollment Completion of Phase I Clinical.. |
| 2023/8/30 | 22:00 | GLOBE | XBiotech Announces Enrollment Completion of Phase II,.. |
| 2023/8/12 | 00:18 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 2023/8/09 | 00:47 | GLOBE | XBiotech Announces First Patient Begins Novel Natrunix.. |
| 2023/5/22 | 22:00 | GLOBE | FDA Authorizes Phase II Study for Natrunix in Rheumatoid.. |
| 2023/5/17 | 22:00 | GLOBE | XBiotech Commences Tender Offer to Purchase up to.. |
